CNTNAP2 and central nervous system cancer: Finally, 93 patients of NSAE were consecutively included, containing 56 with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis, 18 with anti-leucine-rich glioma-inactivated 1 encephalitis, 13 with anti-gamma-aminobutyric acid B receptor encephalitis, 3 with anti-contactin-associated protein-like 2 antibody-associated encephalitis, 2 with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis, and 1 with anti-dipeptidyl-peptidase-like protein-6 encephalitis.